Seong I. Jeon

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Injectable Optoelectronic Probe With In Situ Photoactivation and ROS Monitoring for Oxygen-Dependent Metronomic Photodynamic Cancer Therapy.

Injectable Optoelectronic Probe With In Situ Photoactivation and ROS Monitoring for Oxygen-Dependent Metronomic Photodynamic Cancer Therapy.

Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: March 27, 2026

Dual Delivery of Light/Prodrug Nanoparticles Using Tumor-Implantable Micro Light-Emitting Diode on an Optofluidic System for Combinational Glioma Treatment.

Dual Delivery of Light/Prodrug Nanoparticles Using Tumor-Implantable Micro Light-Emitting Diode on an Optofluidic System for Combinational Glioma Treatment.

Journal: ACS nano
Published: April 29, 2025

Iodinated Cyanoacrylate-Based Novel Liquid Embolic Compositions with Inherent Radiopacity for Endovascular Embolization.

Iodinated Cyanoacrylate-Based Novel Liquid Embolic Compositions with Inherent Radiopacity for Endovascular Embolization.

Journal: Advanced healthcare materials
Published: March 23, 2024

Fluorescence-Based Mono- and Multimodal Imaging for In Vivo Tracking of Mesenchymal Stem Cells.

Fluorescence-Based Mono- and Multimodal Imaging for In Vivo Tracking of Mesenchymal Stem Cells.

Journal: Biomolecules
Published: October 31, 2023

Recent Studies and Progress in the Intratumoral Administration of Nano-Sized Drug Delivery Systems.

Recent Studies and Progress in the Intratumoral Administration of Nano-Sized Drug Delivery Systems.

Journal: Nanomaterials (Basel, Switzerland)
Published: June 30, 2023

Micro-syringe chip-guided intratumoral administration of lipid nanoparticles for targeted anticancer therapy.

Micro-syringe chip-guided intratumoral administration of lipid nanoparticles for targeted anticancer therapy.

Journal: Biomaterials research
Published: June 02, 2023

Cancer-Specific Delivery of Proteolysis-Targeting Chimeras (PROTACs) and Their Application to Cancer Immunotherapy.

Cancer-Specific Delivery of Proteolysis-Targeting Chimeras (PROTACs) and Their Application to Cancer Immunotherapy.

Journal: Pharmaceutics
Published: December 20, 2022

In situ albumin-binding and esterase-specifically cleaved BRD4-degrading PROTAC for targeted cancer therapy.

In situ albumin-binding and esterase-specifically cleaved BRD4-degrading PROTAC for targeted cancer therapy.

Journal: Biomaterials
Published: October 20, 2022

Liposome-mediated PD-L1 multivalent binding promotes the lysosomal degradation of PD-L1 for T cell-mediated antitumor immunity.

Liposome-mediated PD-L1 multivalent binding promotes the lysosomal degradation of PD-L1 for T cell-mediated antitumor immunity.

Journal: Biomaterials
Published: June 07, 2022

Comparative study of cathepsin B-cleavable linkers for the optimal design of cathepsin B-specific doxorubicin prodrug nanoparticles for targeted cancer therapy.

Comparative study of cathepsin B-cleavable linkers for the optimal design of cathepsin B-specific doxorubicin prodrug nanoparticles for targeted cancer therapy.

Journal: Biomaterials
Published: May 30, 2022

Nano-sized drug delivery systems to potentiate the immune checkpoint blockade therapy.

Nano-sized drug delivery systems to potentiate the immune checkpoint blockade therapy.

Journal: Expert opinion on drug delivery
Published: May 23, 2022

Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation.

Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation.

Journal: Pharmaceutics
Published: February 28, 2022
Showing 1-12 of 18

Last Updated: 09/26/2026